Post-ERCP Pancreatitis Prevention by Stent Insertion (PEPSI)
Study to Reduce Incidence of Post-ERCP Pancreatitis by Stent Insertion in the Main Pancreatic Duct After Unintended Cannulation of the Main Pancreatic Duct
Sponsor: KU Leuven
This NA trial investigates Post-ERCP Acute Pancreatitis and is currently completed. KU Leuven leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Nov 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Aug 2018 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Aug 2018 [monthly]
Completed NA
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2017 — Oct 2017 [monthly]
Unknown Status NA
First recorded
Jul 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- KU Leuven
- Latvijas Universitates Medicinas
- Northern State University, Russia
- Technical University of Munich
For direct contact, visit the study record on ClinicalTrials.gov .